Ovid Therapeutics Inc.
SEC 4 · Filed
0001202098-26-000002Accepted
Applies to the EDGAR acceptance time.
Other time zone
Insider transactionsEvent date Feb 26, 2026
- Security
- Employee Stock Option (Right to Buy)
- Shares
-
65,000
- Price per share
-
0.00
Structured facts
{
"code": "A",
"date": "2026-02-26",
"direction": "A",
"exercise_price": "1.65",
"expiration": "2036-02-25",
"footnotes": {
"F1": "The option will vest in full on February 26, 2027, subject to the Reporting Person\u0027s continuous service through such vesting date."
},
"owners": [
{
"cik": "0001202098",
"name": "PAPADOPOULOS STELIOS",
"roles": [
"director"
],
"title": null
}
],
"ownership": "D",
"post_shares": "65000",
"price": "0",
"row": 1,
"rule_10b5_1": "0",
"security": "Employee Stock Option (Right to Buy)",
"shares": "65000",
"table": "II",
"underlying_security": "Common Stock",
"underlying_shares": "65000"
}